Health data for sale online through browser extensions

Amy Baxter | | Health Exec | Digital Transformation

Seemingly innocuous web browser extensions are actually a gateway for health and other data to be collected––and even put up for sale, according to Geoffrey Fowler, technology columnist for The Washington Post.

Fowler researched the availability of personal data for sale online and determined as many as four million people have leaked personal and corporate secrets through Chrome and Firefox web browser extensions. Extensions, or add-ons and plug-ins, are programs that are downloadable and can improve the web browsing experience by remembering passwords or automatically searching for coupons, Fowler wrote.

But not all these extensions are safe, and “some extensions have a side hustle in spying,” he said.

The leaked data include medical records, such as patient and doctor names and medications. Corporations also were sharing information online, including what they were working on.

See the full story below:

I found your data. It’s for sale.

Amy Baxter
Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Related Content

4 points crucial to the nimble regulation of GenAI
5 tips to learn AI from scratch and for free
Good AI governance can spell the difference between smashing success and mere learning experience
10 ways AI, robotics are improving pediatric care in real-world settings
Partnership on AI valiantly trying to wrap arms around the world
How the FDA sees its role vis-à-vis AI in healthcare

Around the web

AI in Healthcare
4 points crucial to the nimble regulation of GenAI

With generative AI coming into its own, AI regulators must avoid relying too much on principles of risk management—and not enough on those of uncertainty management.

Cardiovascular Business
Q&A: Why are cardiovascular devices involved in so many recalls? FDA policies may be to blame

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Design by Adaptive Theme
Trimed Popup
Trimed Popup